Evidence map›Paper›PMID 30934575›Full record

ArticleNutrients2019

Twelve-Week Protocatechuic Acid Administration Improves Insulin-Induced and Insulin-Like Growth Factor-1-Induced Vasorelaxation and Antioxidant Activities in Aging Spontaneously Hypertensive Rats.

Kunanya Masodsai, Yi-Yuan Lin, Rungchai Chaunchaiyakul, Chia-Ting Su, Shin-Da Lee, Ai-Lun Yang

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Polydatin: A natural compound with multifaceted anticancer properties.Journal of traditional and complementary medicine · 2025
    Review
  5. Article
  6. Article
  7. Targeting L-arginine/NO/cGMP/KFrontiers in pharmacology · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Kunanya MasodsaiInstitute of Sports Sciences, University of Taipei, Taipei 11153, Taiwan. kunanyamasodsai@gmail.com.
Yi-Yuan LinDepartment of Occupational Therapy, Asia University, Taichung 41354, Taiwan. charlet8116@gmail.com.ORCID 0000-0002-6147-0183
Rungchai ChaunchaiyakulCollege of Sports Science and Technology, Mahidol University, Nakhonpathom 73170, Thailand. gmrungchai@gmail.com.
Chia-Ting SuDepartment of Occupational Therapy, College of Medicine, Fu Jen Catholic University, New Taipei City 24205, Taiwan. chiatingsu@gmail.com.
Shin-Da LeeDepartment of Occupational Therapy, Asia University, Taichung 41354, Taiwan. leeshinda@gmail.com.
Ai-Lun YangInstitute of Sports Sciences, University of Taipei, Taipei 11153, Taiwan. yangailun@gmail.com.
Asia University · TWUniversity of Taipei · TWFu Jen Catholic University · TWMahidol University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protocatechuic acid (PCA), a strong antioxidant, has been reported for its cardiovascular-protective effects. This study aimed to investigate the effects of PCA administration on vascular endothelial function, mediated by insulin and insulin-like growth factor-1 (IGF-1), and antioxidant activities in aging hypertension. Thirty-six-week-old male aging spontaneously hypertensive rats were randomly divided into vehicle control (SHR) and PCA (SHR+PCA) groups, while age-matched Wistar⁻Kyoto rats (WKY) served as the normotensive vehicle control group. The oral PCA (200 mg/kg/day) was administered daily for a total of 12 weeks. When the rats reached the age of 48 weeks, the rat aortas were isolated for the evaluation of vascular reactivity and Western blotting. Also, nitric oxide (NO) production and antioxidant activities were examined among the three groups. The results showed that, when compared with the SHR group, the insulin-induced and IGF-1-induced vasorelaxation were significantly improved in the SHR+PCA group. There was no significant difference in the endothelium-denuded vessels among the three groups. After the pre-incubation of phosphatidylinositol 3-kinase (PI3K) or NO synthase (NOS) inhibitors, the vasorelaxation was abolished and comparable among the three groups. The protein levels of insulin receptors, IGF-1 receptors, phospho-protein kinase B (p-Akt)/Akt, and phospho-endothelial NOS (p-eNOS)/eNOS in aortic tissues were significantly enhanced in the SHR+PCA group when compared with the SHR group. Moreover, significant improvements of nitrate/nitrite concentration and antioxidant activities, including superoxide dismutase, catalase, and total antioxidants, were also found in the SHR+PCA group. In conclusion, the 12 weeks of PCA administration remarkably improved the endothelium-dependent vasorelaxation induced by insulin and IGF-1 in aging hypertension through enhancing the PI3K⁻NOS⁻NO pathway. Furthermore, the enhanced antioxidant activities partly contributed to the improved vasorelaxation.

Indexed as

AgingAnimalsAntioxidantsAortaBlood PressureDietary SupplementsGene Expression RegulationHeart RateHumansHydroxybenzoatesInsulinInsulin-Like Growth Factor IMalePolyenesRandom AllocationRatsAntioxidantsdimethyl all-(E)-octacosa-10,12,14,16,18-pentaenedioateHydroxybenzoatesInsulinInsulin-Like Growth Factor IPolyenesprotocatechuic acidelderlyendotheliumhigh blood pressurenitric oxidepolyphenol

Identifiers

PMID30934575
PMCPMC6471824
OpenAlexW2924771164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.